Evidence map›Paper›PMID 12107082›Full record

ReviewThe American journal of pathology2002

Lessons from the alpha2 integrin knockout mouse.

Arthur M Mercurio

Abstract readCommentReview
In one paragraph

Review in The American journal of pathology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Extracellular Matrix as a Regulator of Epidermal Stem Cell Fate.International journal of molecular sciences · 2018
    Review
  5. Article
  6. Contrast imaging in mouse embryos using high-frequency ultrasound.Journal of visualized experiments : JoVE · 2015
    Article
  7. Tenascin-C and integrins in cancer.Cell adhesion & migration · 2015
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Arthur M MercurioDivision of Cancer Biology and Angiogenesis, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA. amercuri@caregroup.harvard.edu

Funding

INTEGRIN FUNCTION AND SIGNALING IN CARCINOMA PROGRESSIONR01CA080789 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MERCURIO, ARTHUR M · 1999 to 2012
$4.7M
NCI NIH HHS CA80789NCI NIH HHS R01 CA080789
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntigens, CDInflammationIntegrin alpha2IntegrinsMiceMice, KnockoutNeoplasmsPhenotypeReceptors, CollagenAntigens, CDIntegrin alpha2IntegrinsReceptors, Collagen

Identifiers

PMID12107082
PMCPMC1850676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.